Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Ellwanger

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Praxis|January 17, 2002
[Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]M Schnorf, U Helfenstein, A Blum, et al.
The British Journal of Dermatology|December 3, 1999
Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatmentA Blum, C U Brand, U Ellwanger, et al.
Cancer|June 15, 1997
Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factorsC U Brand, U Ellwanger, W Stroebel, et al.
Melanoma Research|November 30, 2000
Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence?B Schlagenhauff, B Schittek, U Ellwanger, et al.
Cancer|July 1, 1997
Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinationsB Schlagenhauff, W Stroebel, U Ellwanger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 16, 2004
Value of the clinical history for different users of dermoscopy compared with results of digital image analysisA Blum, R Hofmann-Wellenhof, H Luedtke, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 1, 1995
[The Malignant Melanoma Central Register of the German Society of Dermatology 1983-1993. Epidemiologic developments and current therapeutic management of malignant melanoma of the skin]C Garbe, P Büttner, U Ellwanger, et al.
The Journal of Investigative Dermatology|March 25, 2000
Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanomaH J Blaheta, U Ellwanger, B Schittek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2008
Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasisC Garbe, P Radny, R Linse, et al.
The American Journal of Surgical Pathology|July 14, 1999
Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basinH J Blaheta, B Schittek, H Breuninger, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Praxis|January 17, 2002
[Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]M Schnorf, U Helfenstein, A Blum, et al.
The British Journal of Dermatology|December 3, 1999
Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatmentA Blum, C U Brand, U Ellwanger, et al.
Cancer|June 15, 1997
Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factorsC U Brand, U Ellwanger, W Stroebel, et al.
Melanoma Research|November 30, 2000
Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence?B Schlagenhauff, B Schittek, U Ellwanger, et al.
Cancer|July 1, 1997
Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinationsB Schlagenhauff, W Stroebel, U Ellwanger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 16, 2004
Value of the clinical history for different users of dermoscopy compared with results of digital image analysisA Blum, R Hofmann-Wellenhof, H Luedtke, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 1, 1995
[The Malignant Melanoma Central Register of the German Society of Dermatology 1983-1993. Epidemiologic developments and current therapeutic management of malignant melanoma of the skin]C Garbe, P Büttner, U Ellwanger, et al.
The Journal of Investigative Dermatology|March 25, 2000
Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanomaH J Blaheta, U Ellwanger, B Schittek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2008
Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasisC Garbe, P Radny, R Linse, et al.
The American Journal of Surgical Pathology|July 14, 1999
Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basinH J Blaheta, B Schittek, H Breuninger, et al.
Pageof 3